Presence of antibodies in children and young adults living with at least one SARS-CoV-2 positive person

Evaluation of the serological profile of subjects aged between 4 and 16 years old with at least one SARS-CoV-2 positive cohabitant: a randomized clinical trial

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN91064601

Enrollment

Registered

2020-12-16

Start date

2020-06-12

Completion date

Unknown

Last updated

2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Detection of IgG and IgM antibodies for Sars-Cov-2 in children aged between 4 and 16 years Infections and Infestations COVID-19 (SARS-CoV-2 infection)

Interventions

Families interviewed by telephone to gather information about the family cluster (i.e. age and number of cohabitants, their symptoms and swab results, if performed), the positive subject (i.e. sex, ag

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Between 4 and 16 years old 2. At least one cohabitant with positive result of Sars-Cov-2 3. From the districts of Segrate (MI), Vimodrone (MI), Peschiera Borromeo (MI), Crema (CR), and Lodi (LO)

Exclusion criteria

Exclusion criteria: Does not consent to take part

Design outcomes

Primary

Measure	Time frame
Presence of IgG and IgM antibodies for Sars-Cov-2 using a rapid lateral flow chromatographic test at a single time point.	—

Secondary

Measure	Time frame
1. Age measured at the time of serological test 2. Days from negativization measured at the time of serological test (measured by asking the positive subject for the date of certified negativization [after two negative swabs])	—

Countries

Italy

Contacts

Public ContactGianluca Tartaglia

gianluca.tartaglia@unimi.it+39 (0)2 2692 1196

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026